Clinical trial BI 1472-0001
A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation
Organ | Multiple |
---|---|
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1/1b |
Academic trial | Non |
Sponsor | Boehringer Ingelheim |
EudraCT Identifier | 2021-000460-29 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04973163 |
Last update |